Intracervical Vasopressin for Hysteroscopic Removal of Retained Conception Products

This study focuses on improving the safety and effectiveness of a procedure used to remove retained products of conception, which can occur after childbirth or miscarriage. The research targets individuals undergoing hysteroscopic surgery, a common method for this removal. Researchers are evaluating whether an injection of a drug called vasopressin into the cervix can help complete the procedure more successfully without needing to switch to a different method due to complications like excessive bleeding. This study is important as it could enhance surgical outcomes and reduce the need for additional interventions during this procedure. Participants in this study will be randomly assigned to receive either the vasopressin injection or a placebo during their hysteroscopic surgery. The main goal is to determine if the use of vasopressin helps to complete the surgery without switching methods. Researchers will assess the surgery's success by monitoring factors like the amount of bleeding, how long the surgery takes, and the volume of fluid used. This information will help determine the effectiveness and safety of using vasopressin in this context.